Search for: "Label v Label"
Results 61 - 80
of 13,190
Sorted by Relevance
|
Sort by Date
29 Oct 2010, 4:52 pm
Of note, the labels' appellate team now includes former US Solicitor General Paul Clement, now a partner at King & Spalding.Tenenbaum's defense team has also indicated that it will appeal, arguing that even the reduced award is unconstitutionally excessive.Record Labels' appellate brief in Sony v. [read post]
25 Mar 2013, 11:52 am
See Perez v. [read post]
19 Jun 2019, 11:22 am
Facts: This case (Angela Ruggiero v. [read post]
11 Dec 2010, 7:06 am
The three cases, PLIVA Inc. v. [read post]
15 Apr 2014, 9:29 am
POM Wonderful v. [read post]
5 Sep 2012, 11:10 am
Francis College v. [read post]
18 Mar 2011, 1:23 pm
Maybe, if the decision described off-label use as favorably as Layzer v. [read post]
13 Jan 2016, 12:59 pm
The First Amendment does not protect off-label promotion that is false or misleading.United States v. [read post]
27 Oct 2011, 4:24 am
See, e.g., DeNeui v. [read post]
9 Feb 2016, 6:50 am
" Gonzalez v. [read post]
14 Aug 2012, 8:56 am
The court upheld a directed verdict for the defendants in Namundi v. [read post]
15 Sep 2010, 5:49 am
§337(a); Buckman Co. v. [read post]
2 Mar 2016, 2:56 pm
(National Restaurant Association v. [read post]
7 Nov 2011, 3:20 pm
Reynolds v. [read post]
11 Jun 2015, 4:46 am
Brown v. [read post]
22 Sep 2016, 4:00 am
Even more recently, on September 19, 2016, the Medical Information Working Group (MIWG) filed an amicus brief on these issues with the District of Massachusetts in United States v. [read post]
7 Jan 2019, 1:54 pm
In Merck v. [read post]
13 Jun 2011, 7:00 am
In Hill v. [read post]
23 Apr 2014, 4:30 am
The case was Simpson v. [read post]
23 Mar 2023, 5:32 am
Another relevant aspect to be checked is whether other parts of the label, such as the ones describing dosage and administration and adverse events, mentions the patented use (Amarin v. [read post]
